Human umbilical cord mesenchymal stem cells promote breast cancer metastasis by interleukin-8-and interleukin-6-dependent induction of CD44+/CD24− cells

Cell Transplantation

Volumn 24, Issue 12, 2015, Pages 2585-2599

  Ma, Fengxia ^a   Chen, Dandan ^c   Chen, Fang ^a   Chi, Ying ^a   Han, Zhibo ^a,b   Feng, Xiaoming ^a   Li, Xue ^a   Han, Zhongchao ^a,b  

^a INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

^b National Engineering Research Center of Cell Products   (China)

^c THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

Epithelial to mesenchymal transition (EMT); Interleukin 6 (IL 6); Interleukin 8 (IL 8); Mesenchymal stem cells (MSCs)

Indexed keywords

CD24 ANTIGEN; HERMES ANTIGEN; INTERLEUKIN 6; INTERLEUKIN 8; CD24 PROTEIN, HUMAN; CD44 PROTEIN, HUMAN; IL6 PROTEIN, HUMAN; IL8 PROTEIN, HUMAN; RECOMBINANT PROTEIN;

ARTICLE; BREAST METASTASIS; CELL MIGRATION; COCULTURE; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MCF 7 CELL LINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; BREAST TUMOR; CELL MOTION; CELL PROLIFERATION; CYTOLOGY; DRUG EFFECTS; FEMALE; MCF-7 CELL LINE; MESENCHYMAL STROMA CELL; METABOLISM; METASTASIS; MOUSE; NUDE MOUSE; PATHOLOGY; SECRETION (PROCESS); TUMOR CELL LINE; TUMOR INVASION; UMBILICAL CORD; XENOGRAFT;

ANIMALS; ANTIGENS, CD24; ANTIGENS, CD44; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COCULTURE TECHNIQUES; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; MCF-7 CELLS; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; RECOMBINANT PROTEINS; TRANSPLANTATION, HETEROLOGOUS; UMBILICAL CORD;

EID: 84949796234     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368915X687462     Document Type: Article

References (45)

1. Al-Hajj, M.; Wicha, M. S.; Benito-Hernandez, I. A.; Morrison, S. J.; Clarke, M. F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA 100:3983-3988; 2003.
2. Benoy, I. H.; Salgado, R.; Van Dam, P.; Geboers, K.; Van Marck, E.; Scharpé, S.; Vermeulen, P. B.; Dirix, L. Y. Increased serum interleukin-8 in patients with early and metastatic breast cancer correlates with early dissemination and survival. Clin. Cancer Res. 10:7157-7162; 2004
3. Brabletz, T.; Jung, A.; Spaderna, S.; Hlubek, F.; Kirchner, T. Opinion: Migrating cancer stem cells-An integrated concept of malignant tumour progression. Nat. Rev. Cancer 5:744-749; 2005
4. Bravo-Cordero, J. J.; Hodgson, L.; Condeelis, J. Directed cell invasion and migration during metastasis. Curr. Opin. Cell Biol. 24:277-283; 2012
5. Burger, J. A.; Kipps, T. J. CXCR4: A key receptor in the crosstalk between tumor cells and their microenvironment. Blood 107:1761-1767; 2006
6. Charafe-Jauffret, E.; Ginestier, C.; Iovino, F.; Wicinski, J.; Cervera, N.; Finetti, P.; Hur, M. H.; Diebel, M. E.; Monville, F.; Dutcher, J.; Brown, M.; Viens, P.; Xerri, L.; Bertucci, F.; Stassi, G.; Dontu, G.; Birnbaum, D.; Wicha, M. S. Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. Cancer Res. 69:1302-1313; 2009
7. Chaturvedi, P.; Gilkes, D. M.; Wong, C. C.; Kshitiz; Luo, W.; Zhang, H.; Wei, H.; Takano, N.; Schito, L.; Levchenko, A.; Semenza, G. L. Hypoxia-inducible factor-dependent breast cancer-Mesenchymal stem cell bidirectional signaling promotes metastasis. J. Clin. Invest. 123:189-205; 2013
8. Chavey, C.; Bibeau, F.; Gourgou-Bourgade, S.; Burlinchon, S.; Boissière, F.; Laune, D.; Roques, S.; Lazennec, G. Oestrogen receptor negative breast cancers exhibit high cytokine content. Breast Cancer Res. 9:R15; 2007
9. Chen, F.; Zhou, K.; Zhang, L.; Ma, F.; Chen, D.; Cui, J.; Feng, X.; Yang, S.; Chi, Y.; Han, Z.; Xue, F.; Rong, L.; Ge, M.; Wan, L.; Xu, S.; Du, W.; Lu, S.; Ren, H.; Han, Z. Mesenchymal stem cells induce granulocytic differentiation of acute promyelocytic leukemic cells via IL-6 and MEK/ ERK pathways. Stem Cells Dev. 22:1955-1967; 2013
10. De Luca, A.; Lamura, L.; Gallo, M.; Maffia, V.; Normanno, N. Mesenchymal stem cell-derived interleukin-6 and vascular endothelial growth factor promote breast cancer cell migration. J. Cell. Biochem. 113:3363-3370; 2012
11. El-Haibi, C. P.; Bell, G. W.; Zhang, J.; Collmann, A. Y.; Wood, D.; Scherber, C. M.; Csizmadia, E.; Mariani, O.; Zhu, C.; Campagne, A.; Toner, M.; Bhatia, S. N.; Irimia, D.; Vincent-Salomon, A.; Karnoub, A. E. Critical role for lysyl oxidase in mesenchymal stem cell-driven breast cancer malignancy. Proc. Natl. Acad. Sci. USA 109:17460-17465; 2012
12. Fernando, R. I.; Castillo, M. D.; Litzinger, M.; Hamilton, D. H.; Palena, C. IL-8 signaling plays a critical role in the epithelial-mesenchymal transition of human carcinoma cells. Cancer Res. 71:5296-5306; 2011
13. Fritz, V.; Jorgensen, C. Mesenchymal stem cells: An emerging tool for cancer targeting and therapy. Curr. Stem Cell Res. Ther. 3:32-42; 2008
14. Ginestier, C.; Liu, S.; Diebel, M. E.; Korkaya, H.; Luo, M.; Brown, M.; Wicinski, J.; Cabaud, O.; Charafe-Jauffret, E.; Birnbaum, D.; Guan, J. L.; Dontu, G.; Wicha, M. S. CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts. J. Clin. Invest.120:485-497; 2010
15. Hall, B.; Dembinski, J.; Sasser, A. K.; Studeny, M., Andreeff, M.; Marini, F. Mesenchymal stem cells in cancer: Tumor-associated fibroblasts and cell-based delivery vehicles. Int. J. Hematol. 86:8-16; 2007
16. Hennessy, B. T.; Gonzalez-Angulo, A. M.; Stemke-Hale, K.; Gilcrease, M. Z.; Krishnamurthy, S.; Lee, J. S.; Fridlyand, J.; Sahin, A.; Agarwal, R.; Joy, C.; Liu, W.; Stivers, D.; Baggerly, K.; Carey, M.; Lluch, A.; Monteagudo, C.; He, X.; Weigman, V.; Fan, C.; Palazzo, J.; Hortobagyi, G. N.; Nolden, L. K.; Wang, N. J.; Valero, V.; Gray, J. W.; Perou, C. M.; Mills, G. B. Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics. Cancer Res. 69:4116-4124; 2009
17. Karnoub, A. E.; Dash, A. B.; Vo, A. P.; Sullivan, A.; Brooks, M. W.; Bell, G. W.; Richardson, A. L.; Polyak, K.; Tubo, R.; Weinberg, R. A. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449:557-563; 2007
18. Kode, J. A.; Mukherjee, S.; Joglekar, M. V.; Hardikar, A. A. Mesenchymal stem cells: Immunobiology and role in immunomodulation and tissue regeneration. Cytotherapy 11:377-391; 2009
19. Korkaya, H.; Liu, S.; Wicha, M. S. Breast cancer stem cells; cytokine networks; and the tumor microenvironment. J. Clin. Invest. 121:3804-3809; 2011
20. Lehrer, S.; Diamond, E. J.; Mamkine, B.; Stone, N. N.; Stock, R. G. Serum interleukin-8 is elevated in men with prostate cancer and bone metastases. Technol. Cancer Res. Treat. 3:411; 2004
21. Li, H.-J.; Reinhardt, F.; Herschman, H. R.; Weinberg, R. A. Cancer-stimulated mesenchymal stem cells create a carcinoma stem cell niche via prostaglandin E2 signaling. Cancer Discov. 2:840-855; 2012
22. Liao, W.; Xie, J.; Zhong, J.; Liu, Y.; Du, L.; Zhou, B.; Xu, J.; Liu, P.; Yang, S.; Wang, J.; Han, Z.; Han, Z. C. Therapeutic effect of human umbilical cord multipotent mesenchymal stromal cells in a rat model of stroke. Transplantation 87:350-359; 2009
23. Liu, S.; Ginestier, C.; Ou, S. J.; Clouthier, S. G.; Patel, S. H.; Monville, F.; Korkaya, H.; Heath, A.; Dutcher, J.; Kleer, C. G.; Jung, Y.; Dontu, G.; Taichman, R.; Wicha, M. S. Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks. Cancer Res. 71:614-624; 2011
24. Loebinger, M. R.; Eddaoudi, A.; Davies, D.; Janes, S. M. Mesenchymal stem cell delivery of TRAIL can eliminate metastatic cancer. Cancer Res. 69:4134-4142; 2009
25. Lu, L. L.; Liu, Y. J.; Yang, S. G.; Zhao, Q. J.; Wang, X.; Gong, W.; Han, Z. B.; Xu, Z. S.; Lu, Y. X.; Liu, D.; Chen, Z. Z.; Han, Z. C. Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica 91: 1017-1026; 2006
26. Mani, S. A.; Guo, W.; Liao, M. J.; Eaton, E. N.; Ayyanan, A.; Zhou, A. Y.; Brooks, M.; Reinhard, F.; Zhang, C. C.; Shipitsin, M.; Campbell, L. L.; Polyak, K.; Brisken, C.; Yang, J.; Weinberg, R. A. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133:704-715; 2008
27. Mantovani, A.; Savino, B.; Locati, M.; Zammataro, L.; Allavena, P.; Bonecchi, R. The chemokine system in cancer biology and therapy. Cytokine Growth Factor Rev. 21:27-39; 2010
28. Müller, A.; Homey, B.; Soto, H.; Ge, N.; Catron, D.; Buchanan, M. E.; McClanahan, T.; Murphy, E.; Yuan, W.; Wagner, S. N.; Barrera, J. L.; Mohar, A.; Verástegui, E.; Zlotnik, A. Involvement of chemokine receptors in breast cancer metastasis. Nature 410:50-56; 2001
29. Nakaya, Y.; Sheng, G. Epithelial to mesenchymal transition during gastrulation: An embryological view. Dev. Growth Differ. 50:755-766; 2008
30. Ren, H.; Zhao, Q.; Cheng, T.; Lu, S.; Chen, Z.; Meng, L.; Zhu, X; Yang, S.; Xing, W.; Xiao, Y.; Ren, Q.; Chi, Y.; Gu, D.; Yang, R.; Han, Z. C. No contribution of umbilical cord mesenchymal stromal cells to capillarization and venularization of hepatic sinusoids accompanied by hepatic differentiation in carbon tetrachloride-induced mouse liver fibrosis. Cytotherapy 12:371-383; 2010
31. Rhodes, L. V.; Antoon, J. W.; Muir, S. E.; Elliott, S.; Beckman, B. S.; Burow, M. E. Effects of human mesenchymal stem cells on ER-positive human breast carcinoma cells mediated through ER-SDF-1/CXCR4 crosstalk. Mol. Cancer 9: 295; 2010
32. Sansone, P.; Storci, G.; Tavolari, S.; Guarnieri, T.; Giovannini, C.; Taffurelli, M.; Ceccarelli, C.; Santini, D.; Paterini, P.; Marcu, K. B.; Chieco, P.; Bonafè, M. IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland. J. Clin. Invest. 117:3988-4002; 2007
33. Sheridan, C.; Kishimoto, H.; Fuchs, R. K.; Mehrotra, S.; Bhat-Nakshatri, P.; Turner, C. H.; Goulet, R., Jr.; Badve, S.; Nakshatri, H. CD44+/CD24-breast cancer cells exhibit enhanced invasive properties: An early step necessary for metastasis. Breast Cancer Res. 8:R59; 2006
34. Singer, C. F.; Kronsteiner, N.; Hudelist, G.; Marton, E.; Walter, I.; Kubista, M.; Czerwenka, K.; Schreiber, M.; Seifert, M.; Kubista, E. Interleukin 1 system and sex steroid receptor expression in human breast cancer: Interleukin 1alpha protein secretion is correlated with malignant phenotype. Clin. Cancer Res. 9: 4877-4883; 2003
35. Singh, J. K.; Farnie, G.; Bundred, N. J.; Simões, B. M.; Shergill, A.; Landberg, G.; Howell, S. J.; Clarke, R. B. Targeting CXCR1/2 significantly reduces breast cancer stem cell activity and increases the efficacy of inhibiting HER2 via HER2-dependent and -independent mechanisms. Clin. Cancer Res. 19: 643-656; 2013
36. Stoff-Khalili, M. A.; Rivera, A. A.; Mathis, J. M.; Banerjee, N. S.; Moon, A. S.; Hess, A.; Rocconi, R. P.; Numnum, T. M.; Everts, M.; Chow, L. T.; Douglas, J. T.; Siegal, G. P.; Zhu, Z. B.; Bender, H. G.; Dall, P.; Stoff, A.; Pereboeva, L.; Curiel, D. T. Mesenchymal stem cells as a vehicle for targeted delivery of CRAds to lung metastases of breast carcinoma. Breast Cancer Res. Treat. 105:157-167; 2007
37. Sullivan, N. J.; Sasser, A. K.; Axel, A. E.; Vesuna, F.; Raman, V.; Ramirez, N.; Oberyszyn, T. M.; Hall, B. M. Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells. Oncogene 28:2940-2947; 2009
38. Sun, J.; Han, Z. B.; Liao, W.; Yang, S. G.; Yang, Z.; Yu, J.; Meng, L.; Wu, R.; Han, Z. C. Intrapulmonary delivery of human umbilical cord mesenchymal stem cells attenuates acute lung injury by expanding CD4+CD25+ Forkhead Boxp3 (FOXP3)+ regulatory T cells and balancing anti-and pro-inflammatory factors. Cell. Physiol. Biochem. 27:587-596; 2011
39. Thiery, J. P.; Sleeman, J. P. Complex networks orchestrate epithelial-mesenchymal transitions. Nat. Rev. Mol. Cell Biol. 7:131-142; 2006
40. Tian, K.; Yang, S.; Ren, Q.; Han, Z.; Lu, S.; Ma, F.; Zhang, L.; Han, Z. p38 MAPK contributes to the growth inhibition of leukemic tumor cells mediated by human umbilical cord mesenchymal stem cells. Cell. Physiol. Biochem. 26: 799-808; 2010
41. Wang, H.; Cao, F.; De, A.; Cao, Y.; Contag, C.; Gambhir, S. S.; Wu, J. C.; Chen, X. Trafficking mesenchymal stem cell engraftment and differentiation in tumor-bearing mice by bioluminescence imaging. Stem Cells 27:1548-1558; 2009
42. Wegmeyer, H.; Bröske, A. M.; Leddin, M.; Kuentzer, K.; Nisslbeck, A. K.; Hupfeld, J.; Wiechmann, K.; Kuhlen, J.; von Schwerin, C.; Stein, C.; Knothe, S.; Funk, J.; Huss, R.; Neubauer, M. Mesenchymal stromal cell characteristics vary depending on their origin. Stem Cells Dev. 22:2606-2618; 2013
43. Xu, Q.; Wang, L.; Li, H.; Han, Q.; Li, J.; Qu, X.; Huang, S.; Zhao, R. C. Mesenchymal stem cells play a potential role in regulating the establishment and maintenance of epithelial-mesenchymal transition in MCF7 human breast cancer cells by paracrine and induced autocrine TGF-b. Int. J. Oncol. 41:959-968; 2012
44. Yan, C.; Li, S.; Li, Z.; Peng, H.; Yuan, X.; Jiang, L.; Zhang, Y.; Fan, D.; Hu, X.; Yang, M.; Xiong, D. Human umbilical cord mesenchymal stem cells as vehicles of CD20-specific TRAIL fusion protein delivery: A double-target therapy against non-Hodgkin’s lymphoma. Mol. Pharm. 10:142-151; 2013
45. Yu, J.; Zheng, C.; Ren, X.; Li, J.; Liu, M.; Zhang, L.; Liang, L.; Du, W.; Han, Z. C. Intravenous administration of bone marrow mesenchymal stem cells benefits experimental autoimmune myasthenia gravis mice through an immunomodulatory action. Scand. J. Immunol. 72:242-249; 2010.